Financials
- Market Capitalization 2.36 B
- Employee 357
- Founded 2009
- CEO N/A
- Website www.nurixtx.com
- Headquarter Delaware, United States
- FIGI BBG00SDJ8M78
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.03
Rapporto prezzo/fatturato
44.74
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1865 | VCEL Vericel Corporation - Common Stock | 47.49 USD | +1.04% | +0.87% | +25.40% | +30.65% | 2.43 B USD | ||
| 1872 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 40.55 USD | -1.65% | +2.35% | +36.58% | -6.55% | 2.41 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.62 USD | -1.10% | -9.21% | +59.75% | +540.61% | 2.35 B USD | ||
| 1888 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.52 USD | -7.40% | -8.63% | +14.64% | +134.99% | 2.35 B USD |